{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T03:12:18Z","timestamp":1775617938279,"version":"3.50.1"},"reference-count":63,"publisher":"Impact Journals, LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2021,1,31]]},"DOI":"10.18632\/aging.202500","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T18:14:21Z","timestamp":1611080061000},"page":"1571-1590","source":"Crossref","is-referenced-by-count":28,"title":["Fighting the storm: could novel anti-TNF\u03b1 and anti-IL-6 <i>C. sativa<\/i> cultivars tame cytokine storm in COVID-19?"],"prefix":"10.18632","volume":"13","author":[{"given":"Anna","family":"Kovalchuk","sequence":"first","affiliation":[{"name":"Pathway Research Inc., Lethbridge, AB T1K7X8, Canada"},{"name":"University of Calgary, Cumming School of Medicine, Calgary, AB T2N 1N4, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[{"name":"Pathway Research Inc., Lethbridge, AB T1K7X8, Canada"},{"name":"University of Lethbridge, Lethbridge, AB T1K3M4, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongping","family":"Li","sequence":"additional","affiliation":[{"name":"Pathway Research Inc., Lethbridge, AB T1K7X8, Canada"},{"name":"University of Lethbridge, Lethbridge, AB T1K3M4, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocio","family":"Rodriguez-Juarez","sequence":"additional","affiliation":[{"name":"Pathway Research Inc., Lethbridge, AB T1K7X8, Canada"},{"name":"University of Lethbridge, Lethbridge, AB T1K3M4, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Slava","family":"Ilnytskyy","sequence":"additional","affiliation":[{"name":"Pathway Research Inc., Lethbridge, AB T1K7X8, Canada"},{"name":"University of Lethbridge, Lethbridge, AB T1K3M4, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Kovalchuk","sequence":"additional","affiliation":[{"name":"Pathway Research Inc., Lethbridge, AB T1K7X8, Canada"},{"name":"University of Lethbridge, Lethbridge, AB T1K3M4, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Kovalchuk","sequence":"additional","affiliation":[{"name":"Pathway Research Inc., Lethbridge, AB T1K7X8, Canada"},{"name":"University of Lethbridge, Lethbridge, AB T1K3M4, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2021,1,19]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"e7560","DOI":"10.7759\/cureus.7560","article-title":"A comprehensive literature review on the clinical presentation, and management of the pandemic coronavirus disease 2019 (COVID-19).","volume":"1","author":"Baig","year":"2020","journal-title":"Cureus"},{"key":"2","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019.","volume":"38","author":"Ma","year":"2020","journal-title":"N Engl J Med"},{"key":"3","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","article-title":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology.","volume":"3","author":"Perlman","year":"2017","journal-title":"Semin Immunopathol"},{"key":"4","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention.","volume":"2","author":"Ng","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"5","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1172\/JCI31487","article-title":"Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases.","volume":"11","author":"Wynn","year":"2007","journal-title":"J Clin Invest"},{"key":"6","doi-asserted-by":"publisher","first-page":"117583","DOI":"10.1016\/j.lfs.2020.117583","article-title":"COVID-19: melatonin as a potential adjuvant treatment.","volume":"25","author":"Reiter","year":"2020","journal-title":"Life Sci"},{"key":"7","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1172\/JCI137647","article-title":"SARS-CoV-2: a storm is raging.","volume":"13","author":"Ho","year":"2020","journal-title":"J Clin Invest"},{"key":"8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40779-020-00240-0","article-title":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.","volume":"7","author":"Yan","year":"2020","journal-title":"Mil Med Res"},{"key":"9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.","volume":"39","author":"Xia","year":"2020","journal-title":"Lancet"},{"key":"10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/cmi.2015.74","article-title":"The cytokine storm of severe influenza and development of immunomodulatory therapy.","volume":"1","author":"Yang","year":"2016","journal-title":"Cell Mol Immunol"},{"key":"11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/rmv.2141","article-title":"Interleukin-6 in covid-19: a systematic review and meta-analysis.","volume":"3","author":"Haghbayan","year":"2020","journal-title":"Rev Med Virol"},{"key":"12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12967-020-02333-9","article-title":"anti-IL6R role in treatment of COVID-19-related ARDS.","volume":"1","author":"Ascierto","year":"2020","journal-title":"J Transl Med"},{"key":"13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10354-015-0344-y","article-title":"anti-TNF in rheumatoid arthritis: an overview.","volume":"16","author":"Aletaha","year":"2015","journal-title":"Wien Med Wochenschr"},{"key":"14","doi-asserted-by":"publisher","first-page":"959","DOI":"10.2217\/imt-2016-0020","article-title":"Immunotherapeutic implications of IL-6 blockade for cytokine storm.","volume":"8","author":"Kishimoto","year":"2016","journal-title":"Immunotherapy"},{"key":"15","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/jmv.20255","article-title":"An interferon-gamma-related cytokine storm in SARS patients.","volume":"7","author":"Lei","year":"2005","journal-title":"J Med Virol"},{"key":"16","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1097\/CM9.0000000000000839","article-title":"Lung transplantation as therapeutic option in acute respiratory distress syndrome for coronavirus disease 2019-related pulmonary fibrosis.","volume":"13","author":"Li","year":"2020","journal-title":"Chin Med J (Engl)"},{"key":"17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis.","volume":"21","author":"Wynn","year":"2008","journal-title":"J Pathol"},{"key":"18","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1365-2567.2011.03522.x","article-title":"Interleukin-23: as a drug target for autoimmune inflammatory diseases.","volume":"13","author":"Huang","year":"2012","journal-title":"Immunology"},{"key":"19","doi-asserted-by":"publisher","first-page":"364","DOI":"10.3389\/fmed.2018.00364","article-title":"IL-17 in rheumatoid arthritis and precision medicine: from synovitis expression to circulating bioactive levels.","volume":"5","author":"Miossec","year":"2019","journal-title":"Front Med (Lausanne)"},{"key":"20","doi-asserted-by":"publisher","first-page":"5455","DOI":"10.1073\/pnas.1422576112","article-title":"Inhibition of TLR2 signaling by small molecule inhibitors targeting a pocket within the TLR2 TIR domain.","volume":"11","author":"Vogel","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"21","doi-asserted-by":"publisher","first-page":"116671","DOI":"10.1016\/j.lfs.2019.116671","article-title":"TLRs in pulmonary diseases.","volume":"23","author":"Syed","year":"2019","journal-title":"Life Sci"},{"key":"22","doi-asserted-by":"publisher","first-page":"a001651","DOI":"10.1101\/cshperspect.a001651","article-title":"The nuclear factor NF-kappaB pathway in inflammation.","volume":"1","author":"Lawrence","year":"2009","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"23","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1165\/rcmb.2016-0121TR","article-title":"Immune mechanisms in pulmonary fibrosis.","volume":"5","author":"Hartl","year":"2016","journal-title":"Am J Respir Cell Mol Biol"},{"key":"24","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1136\/thoraxjnl-2016-209753","article-title":"\u2018WNT-er is coming\u2019: Wnt signalling in chronic lung diseases.","volume":"7","author":"K\u00f6nigshoff","year":"2017","journal-title":"Thorax"},{"key":"25","doi-asserted-by":"publisher","first-page":"e2142","DOI":"10.1371\/journal.pone.0002142","article-title":"Functional Wnt signaling is increased in idiopathic pulmonary fibrosis.","volume":"3","author":"Eickelberg","year":"2008","journal-title":"PLoS One"},{"key":"26","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1172\/JCI20997","article-title":"Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis.","volume":"11","author":"Strieter","year":"2004","journal-title":"J Clin Invest"},{"key":"27","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1111\/j.1476-5381.2011.01238.x","article-title":"Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.","volume":"16","author":"Russo","year":"2011","journal-title":"Br J Pharmacol"},{"key":"28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/imr.12621","article-title":"Overview of the IL-1 family in innate inflammation and acquired immunity.","volume":"28","author":"Dinarello","year":"2018","journal-title":"Immunol Rev"},{"key":"29","doi-asserted-by":"publisher","first-page":"102468","DOI":"10.1016\/j.jaut.2020.102468","article-title":"The anti-viral facet of anti-rheumatic drugs: lessons from COVID-19.","volume":"11","author":"Gerli","year":"2020","journal-title":"J Autoimmun"},{"key":"30","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/SHK.0000000000000207","article-title":"Elevated expression of IL-23\/IL-17 pathway-related mediators correlates with exacerbation of pulmonary inflammation during polymicrobial sepsis.","volume":"4","author":"De Maio","year":"2014","journal-title":"Shock"},{"key":"31","doi-asserted-by":"publisher","first-page":"L6","DOI":"10.1152\/ajplung.00344.2017","article-title":"IL-17 in the lung: the good, the bad, and the ugly.","volume":"31","author":"Moore","year":"2018","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"32","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/S0002-9440(10)62289-4","article-title":"CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury.","volume":"16","author":"Toews","year":"2005","journal-title":"Am J Pathol"},{"key":"33","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1165\/rcmb.2005-0253OC","article-title":"The CC chemokine ligand 2 (CCL2) mediates fibroblast survival through IL-6.","volume":"3","author":"Rennard","year":"2007","journal-title":"Am J Respir Cell Mol Biol"},{"key":"34","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1164\/rccm.201401-0079OC","article-title":"Wnt coreceptor Lrp5 is a driver of idiopathic pulmonary fibrosis.","volume":"19","author":"Gottardi","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"35","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10753-004-6647-6","article-title":"ICAM-1, ICAM-2 and ICAM-3 in the sera of patients with idiopathic pulmonary fibrosis.","volume":"2","author":"Molyvdas","year":"2004","journal-title":"Inflammation"},{"key":"36","doi-asserted-by":"publisher","first-page":"e1003520","DOI":"10.1371\/journal.ppat.1003520","article-title":"An anti-human ICAM-1 antibody inhibits rhinovirus-induced exacerbations of lung inflammation.","volume":"9","author":"Walton","year":"2013","journal-title":"PLoS Pathog"},{"key":"37","doi-asserted-by":"publisher","first-page":"e255","DOI":"10.1016\/S2665-9913(20)30092-8","article-title":"Preventing COVID-19-induced pneumonia with anticytokine therapy.","volume":"2","author":"Ardizzone","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"38","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s12967-020-02339-3","article-title":"Why tocilizumab could be an effective treatment for severe COVID-19?","volume":"1","author":"Wei","year":"2020","journal-title":"J Transl Med"},{"key":"39","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.hjc.2020.03.002","article-title":"The greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): rationale and study design.","volume":"6","author":"Saroglou","year":"2020","journal-title":"Hellenic J Cardiol"},{"key":"40","first-page":"e40","article-title":"Metronidazole; a potential novel addition to the COVID-19 treatment regimen.","volume":"8","author":"Parvizi","year":"2020","journal-title":"Arch Acad Emerg Med"},{"key":"41","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1002\/phar.2397","article-title":"Considerations for Statin Therapy in Patients with COVID-19.","volume":"4","author":"Khalili","year":"2020","journal-title":"Pharmacotherapy"},{"key":"42","doi-asserted-by":"publisher","first-page":"e002128","DOI":"10.1161\/JAHA.115.002128","article-title":"Colchicine acutely suppresses local cardiac production of inflammatory cytokines in patients with an acute coronary syndrome.","volume":"4","author":"Patel","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"43","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1042\/CS20160090","article-title":"Colchicine therapy in acute coronary syndrome patients acts on caspase-1 to suppress NLRP3 inflammasome monocyte activation.","volume":"13","author":"Patel","year":"2016","journal-title":"Clin Sci (Lond)"},{"key":"44","doi-asserted-by":"publisher","DOI":"10.23812\/CONTI-E","article-title":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies.","author":"Kritas","year":"2020","journal-title":"J Biol Regul Homeost Agents"},{"key":"45","doi-asserted-by":"publisher","first-page":"110698","DOI":"10.1016\/j.biopha.2020.110698","article-title":"The role of interleukin 6 inhibitors in therapy of severe COVID-19.","volume":"13","author":"Samsonov","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"46","doi-asserted-by":"publisher","first-page":"105954","DOI":"10.1016\/j.ijantimicag.2020.105954","article-title":"Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality.","volume":"5","author":"Wang","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"47","doi-asserted-by":"publisher","first-page":"07","DOI":"10.1101\/2020.07.20.20157503","article-title":"COVIDOSE: low-dose tocilizumab in the treatment of covid-19.","volume":"202","author":"Danahey","year":"2020","journal-title":"medRxiv"},{"key":"48","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1016\/j.transproceed.2020.06.003","article-title":"Successful treatment of severe COVID-19 pneumonia with clazakizumab in a heart transplant recipient: a case report.","volume":"5","author":"Jordan","year":"2020","journal-title":"Transplant Proc"},{"key":"49","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1371\/journal.pone.0000108","article-title":"Soluble TNF mediates the transition from pulmonary inflammation to fibrosis.","volume":"1","author":"Aidinis","year":"2006","journal-title":"PLoS One"},{"key":"50","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/jmv.25685","article-title":"Coronavirus infections and immune responses.","volume":"9","author":"Wu","year":"2020","journal-title":"J Med Virol"},{"key":"51","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218171","article-title":"COVID-19 in patients with rheumatological diseases treated with anti-TNF.","author":"Moreira","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"52","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1159\/000501745","article-title":"Aging is a powerful risk factor for type 2 diabetes mellitus independent of body mass index.","volume":"6","author":"Steinhauser","year":"2020","journal-title":"Gerontology"},{"key":"53","doi-asserted-by":"publisher","first-page":"7809","DOI":"10.1073\/pnas.0711241105","article-title":"Modulation of TNF-alpha-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-alpha production and facilitates viral entry.","volume":"10","author":"Ishizaka","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"54","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/S0140-6736(20)30858-8","article-title":"Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed.","volume":"39","author":"Hussell","year":"2020","journal-title":"Lancet"},{"key":"55","article-title":"New Research Suggests Terpenes And CBD Work 2X\u2019s Better For Covid-19 Inflammation Than Corticosteroid.","volume":"202","author":"Earlenbaugh","year":"2020","journal-title":"Forbes"},{"key":"56","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","article-title":"Inflammaging: a new immune-metabolic viewpoint for age-related diseases.","volume":"1","author":"Santoro","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"57","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: a fast spliced aligner with low memory requirements.","volume":"1","author":"Salzberg","year":"2015","journal-title":"Nat Methods"},{"key":"58","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features.","volume":"3","author":"Shi","year":"2014","journal-title":"Bioinformatics"},{"key":"59","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.","volume":"1","author":"Anders","year":"2014","journal-title":"Genome Biol"},{"key":"60","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1093\/bioinformatics\/btt285","article-title":"Pathview: an R\/Bioconductor package for pathway-based data integration and visualization.","volume":"2","author":"Brouwer","year":"2013","journal-title":"Bioinformatics"},{"key":"61","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H","article-title":"The kyoto encyclopedia of genes and genomes\u2014KEGG.","volume":"1","author":"Kell","year":"2000","journal-title":"Yeast"},{"key":"62","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/1471-2105-10-161","article-title":"GAGE: generally applicable gene set enrichment for pathway analysis.","volume":"1","author":"Woolf","year":"2009","journal-title":"BMC Bioinformatics"},{"key":"63","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing.","volume":"5","author":"Hochberg","year":"1995","journal-title":"Journal of the Royal Statistical Society Series B (Methodological)"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.202500","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T16:05:28Z","timestamp":1617725128000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.202500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,19]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,1,31]]}},"alternative-id":["202500","33465050"],"URL":"https:\/\/doi.org\/10.18632\/aging.202500","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,19]]}}}